What Securecell does

Securecell AG is a privately held Swiss bioprocess automation and digitalization company founded in 2010 as successor to ETH Zurich spin-off Biospectra AG (1992), headquartered in Urdorf with operating subsidiaries in the United States, Netherlands, and Portugal. The company builds a modular platform combining hardware (automated sampling systems, high-throughput bioreactor platforms) with SCADA-style process information management software, targeting biopharmaceutical manufacturers, biotechnology firms, CDMOs, and academic research centers.

Core products include Lucullus PIMS, a vendor-independent SCADA platform that orchestrates process planning, media preparation, sampling, and evaluation with GMP-compliant versions; Numera 3, a tube-based automated sampling and PAT system capable of servicing up to 16 bioreactors with integrated dilution, filtration, and cooled storage; Integra 1, a fully integrated USP-PAT-DSP platform with up to 64 automated 200 mL bioreactors using patented reusable sensor port technology; Axon HT, a vial transport solution for Sartorius Ambr 250 systems; and the Seraccess medtech line for blood parameter monitoring and artificial pancreas development. The company maintains an installed base of over 1,000 installations and over 6,000 integrated hardware/software solutions globally.

Securecell operates a hybrid go-to-market combining direct enterprise field sales via six named regional Key Account Managers with an international distributor network spanning 13+ countries, plus strategic technology partnerships (Roche Custom Biotech, Getinge Applikon, DataHow AG, CGT Catapult consortium). Revenue is generated through hardware sales, software licenses with maintenance subscriptions, professional services, and ongoing support contracts, with no publicly disclosed pricing. The company has no disclosed external funding rounds and is founder-led by CEO Carlo Andretta.

Name

Securecell

Legal name

Securecell AG

Website

https://securecell.ch

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Securecell AG is a privately held Swiss company that builds modular bioprocess automation hardware and SCADA software (Lucullus, Numera, Integra 1) for biopharmaceutical manufacturers, biotech firms, CDMOs, and academic research centers, with an installed base exceeding 1,000 sites globally.

Ownership category

akta.pro rank

Product category

Bioprocess Automation Software

NAICS

Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Software Publishers (5132), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Industrial Instruments For Measurement, Display, And Control (3823), Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Process Analytical Technology (PAT) & In-Line/At-Line Analytics (spectroscopy, sensors, monitoring) (HLAAAJAD)

akta.pro secondary industries

Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), Bioprocess Development & Scale-Up/Scale-Down Platforms (DoE, high-throughput, modeling) (HLAAAJAF), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

• Bioprocess automation software
• Process analytical technology
• Automated sampling systems
• High-throughput bioprocessing
• SCADA bioprocess software

Headquarters

HQ city

Urdorf

HQ country

Switzerland

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Hardware Sales - Bioprocess Systems: Sale of physical products including Numera automated sampling systems, Integra 1 high-throughput bioprocessing platforms, Axon HT vial transport solutions, and associated consumables and spare parts. Hardware products are sold directly and through distributor networks globally.
2. Software Licenses and Subscriptions: Lucullus Process Information Management System is offered as a comprehensive bioprocess software solution. Lucullus 24.1.2 GMP is the current supported version (superseding Lucullus 3.10.5 GMP end-of-life April 2027). Software likely sold via perpetual license with maintenance/subscription.
3. Professional Services: Custom automation solutions, project-based engineering, installation, commissioning, training (Academy), and technical support services. Includes custom automation projects for biopharma customers ranging from small lab fermenters to GMP production systems.
4. Support and Maintenance: Ongoing technical support, repair services, spare parts, and RMA (Return Merchandise Authorization) services. Support services include contact support, FAQ knowledge base, product manuals, tutorials, and training materials.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels10 records

Core offering

Securecell develops and sells modular bioprocess automation platforms combining hardware and software for the biopharmaceutical industry. Core offerings include the Lucullus SCADA Process Information Management System, Numera automated sampling systems, and the Integra 1 high-throughput bioprocessing platform integrating upstream processing, process analytical technology (PAT), and downstream processing. The company also develops MedTech blood parameter monitoring systems (Seraccess) including an artificial pancreas device system.

Product overview

Securecell offers a platform-plus-modules architecture serving both biotech and medtech sectors. In biotech, the core product is Lucullus® SCADA software which serves as the central 'brain' orchestrating all bioprocess operations, paired with Numera® 3 automated sampling hardware. The Integra 1 platform extends capabilities for high-throughput bioprocessing with integrated PAT and DSP workflows, while Axon HT provides autosampling connectivity for Ambr 250 systems. In medtech, Seraccess® technology enables critical blood parameter monitoring including an artificial pancreas device system. All products are designed to work together within an integrated ecosystem, with Lucullus software coordinating sampling, measurement, process monitoring and control across the portfolio.

Differentiator

Problem solved

Functional benefit

Brands

• Lucullus®: Comprehensive SCADA software solution for bioprocess digitalization and automation
• Numera®
• Integra1
• Axon HT
• Seraccess®

Products and services

• Lucullus Comprehensive SCADA (Supervisory Control and Data Acquisition) software for bioprocess digitalization and automation. Functions as the central orchestrating platform for bioprocess workflows including process planning, media preparation, process execution, sample management, and process evaluation. Vendor-independent, integrates multiple devices and lab equipment.
• Numera 3 Automated Sampling System Tube-based automated bioprocess sampling and PAT solution with modular design supporting sampling from up to 16 bioreactors. Features integrated dilution (up to 1:100), crossflow filtration, and cooled sample storage (4-20°C). Supports high-frequency sampling (every 6 minutes) and integrates with up to 6 analyzers.
• Integra 1 High-Throughput Bioprocessing Platform Fully integrated end-to-end platform for bioprocess development with 32-64 fully automated bioreactors at 200 mL working volume. Combines upstream processing (USP), process analytical technology (PAT), and downstream processing (DSP) in one platform. Features reusable single-use Reactor Array Modules with patented sensor port technology.
• Axon HT Vial Transport Solution Automated vial transport system for Ambr 250 multi-parallel bioreactors enabling automated sample transport from up to 6 Ambr 250 systems to a centralized PAT island. Overcomes distance limitations of conventional autosampling.
• Seraccess Medical Technology Platform Medical technology platform for monitoring critical blood parameters including automated blood sampling and glucose measurement. Includes Seraccess AXM for hospital blood parameter monitoring and Seraccess SENSE for artificial pancreas device system (APDS) providing personalized glucose control.

Quantifiable outcome

• Up to 50% cost savings compared to existing high-throughput technologies
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration17 records

AI capability4 records

Feature7 records

Partnerships

Four partnerships are on record, tiered core.

• Cell and Gene Therapy Catapult Limited (CGT Catapult)coreStrategic or Co-development Partner · 1 January 2024Co-funded by Innovate UK and Innosuisse. Consortium for next-generation automation and PAT implementation in cell and gene therapy manufacturing. Integrates Securecell's Numera and Lucullus with Horiba Aqualog 2D-FE spectroscope, ChemoMetec XcytoMatic XM30 cell counter, and Endress+Hauser Rxn2 Raman spectrometer. Data flows into DataHowLab for hybrid modeling. Aims to improve process monitoring, control, and optimization in CGT manufacturing.
• DataHow AGcoreTechnology or Integration · 1 January 2022Partnership to accelerate bioprocess development through machine learning-based models. DataHow's DataHowLab hybrid modeling software integrates with Lucullus for in-silico process development, scale-up facilitation, and real-time process condition predictions. Also part of CGT Catapult consortium (2024).
• Roche Custom BiotechcoreStrategic or Co-development Partner · 1 January 2020Collaboration focusing on automated sampling and online analytics for bioprocesses. Combines Numera automated sampling platform with Roche analyzers for integrated PAT solutions. Marked as milestone partnership in 2020.
• Getinge ApplikoncoreChannel Partner/ Reseller/ Distributor · 1 January 2015First distribution agreement for Lucullus software, signed in 2015. Applikon (now part of Getinge) distributes Lucullus as part of their bioreactor portfolio, extending Securecell's market reach in the Netherlands and internationally.

Scale indicators5 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Sartorius AG: Global leader in bioprocess solutions including bioreactors (Ambr 250), PAT software (Umetrics), and single-use consumables. Directly competes with Securecell's Numera and Integra 1 platforms, and is a key integration partner for Axon HT.
• Getinge (Applikon): Bioreactor manufacturer and a Securecell distribution partner since 2015 (Lucullus bundled with Applikon bioreactors). Direct peer in bioreactor systems and competes with Integra 1 in upstream process development.
• Eppendorf SE: Manufacturer of bioreactors (DASbox, BioFlo), shakers, and bioprocess consumables. Competes in benchtop and small-scale bioreactor automation segments that overlap with Securecell's high-throughput process development offering.
• Hamilton Company: Provides automated liquid handling, robotics, and bioprocess sampling platforms (e.g., Microlab STAR). Direct competitor in automated sampling and sample-preparation workflows that overlap with Numera 3.
• Repligen Corporation: Specializes in bioprocess tools including tangential flow filtration (TFF) systems, flow spectroscopy, and process analytics. Competes with Numera's crossflow filtration module and Integra 1's PAT integration scope.
• Tecan Group: Provides laboratory automation, liquid handling, and reader/analyzer platforms used in bioprocess PAT. Competes with Numera in automated sampling workflows and with Lucullus in lab orchestration software.

Broad incumbents

• Cytiva (Danaher): Broad bioprocess portfolio spanning bioreactors, filtration, chromatography, and digital/automation tools (Figurate, Unicorn). Competes with Integra 1 high-throughput systems and serves as an integrator of Lucullus-style SCADA layers.
• Thermo Fisher Scientific: Provides bioprocess production systems, PAT analyzers, and software platforms. Competes with Securecell's full stack and is a key integration partner (HPLC integration into Numera/Integra 1 PAT island).
• Merck KGaA / MilliporeSigma: Operates a large bioprocess portfolio including single-use systems, process control software, and PAT tools. Competes broadly with Securecell's automation stack and is a potential integrator of Lucullus-class SCADA layers.

Emerging players

• DataHow AG: Swiss-based hybrid modeling and digital twin software for bioprocess development. Strategic technology partner of Securecell (DataHowLab integrates with Lucullus) and member of the CGT Catapult consortium; partial overlap in in-silico process development adjacent to Lucullus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Securecell1
• YouTubeyoutube.com/channel/UCqvuB5-SdRMfAlDPBjcyYLg
• LinkedInlinkedin.com/company/securecell-ag

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Securecell